The global pharmaceutical industry experienced a 58% drop in company filings mentions of blockchain in Q3 2023 compared with the previous quarter, with the highest share accounted for by Merck with 300% year-on-year increase, according to GlobalData’s analysis of over 41 pharmaceutical company filings. GlobalData’s Pharma: Filings Trends & Signals Q3 2023 report delves into earnings call transcripts and quarterly reports within the pharmaceuticals industry, extracting trends, signals, and comparative data to help businesses assess their performance, identify competitive intelligence, evaluate risks, and gain a comprehensive understanding of key industry events. Buy the report here.
Notably, blockchain was one of the most frequently referenced themes in Q3 2023, ranking highest in terms of mentions, ahead of advanced materials and future of work, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, Merck had the greatest increase in references for blockchain in Q3 2023, compared with the previous quarter. GlobalData identified four blockchain-related sentences in the company's filings - 0.1% of all sentences - and an increase of 300% in Q3 2023 compared with Q3 2022.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for blockchain in Q3 2023 was 182.
For further understanding of GlobalData's Pharma: Filings Trends & Signals Q3 2023, buy the report here.